Evidence map›Paper›PMID 40060110›Full record

ArticleJournal of aerosol science2025

Modeling aerosol bolus inhalations in the human lung with the Multiple Path Particle Deposition model: Comparison with experimental data.

B Asgharian, O Price, A A T Borojeni, A P Kuprat, S Colby, R K Singh, R A Corley, C Darquenne

Abstract read
In one paragraph

Article in Journal of aerosol science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

B AsgharianApplied Research Associates, Arlington Division, Raleigh, NC, USA.
O PriceApplied Research Associates, Arlington Division, Raleigh, NC, USA.
A A T BorojeniDepartment of Medicine, University of California, San Diego, CA, USA.
A P KupratPacific Northwest National Laboratory, Richland, WA, USA.
S ColbyPacific Northwest National Laboratory, Richland, WA, USA.
R K SinghPacific Northwest National Laboratory, Richland, WA, USA.
R A CorleyPacific Northwest National Laboratory, Richland, WA, USA.
C DarquenneDepartment of Medicine, University of California, San Diego, CA, USA.

Funding

Multiscale Modeling of Lung Disease-Influenced Aerosol DosimetryU01ES028669 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DARQUENNE, CHANTAL · 2018 to 2022
$3.3M
NIEHS NIH HHS U01 ES028669
6 · The paper itself

Abstract

Existing one-dimensional (1D) models of aerosol dosimetry often ignore mixing mechanisms of inhaled aerosols during their transport in the lung. This mixing or aerosol dispersion results from different physical mechanisms in different regions of the lung. It is a higher order effect, which cannot be directly captured in 1D modeling approaches, and thus is sometimes modeled as a diffusive process. In this study, we improved our recently developed alveolar mixing module incorporated in the multiple path particle dosimetry model (MPPD) to account for flow irreversibility and particle trapping in the alveolar spaces, as well as mixing occurring in the tracheobronchial region. This new version of MPPD was coupled with CFPD-based predictions of aerosol bolus dispersion in the oral airway. The model was used to predict the deposition, dispersion, and mode shift of aerosol bolus inhaled at different penetration depths within the lung for breathing patterns and particle size matching those used in a previous experimental study (Darquenne et al., 2016). Even though a quite simplified approach was used, the computations appear to describe subject-specific and test-specific experimental data reasonably well. The proposed combined dispersion-deposition model can be a useful tool for targeted drug delivery and also for exposure health risk assessment.

Indexed as

bolus inhalationsMPPDparticle dispersionsubject-specific predictions

Identifiers

PMID40060110
PMCPMC11884729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.